Please login to the form below

Not currently logged in
Email:
Password:

research strategy

This page shows the latest research strategy news and features for those working in and with pharma, biotech and healthcare.

Pharma marketers’ blog: How to prioritise, perform and prevail

Pharma marketers’ blog: How to prioritise, perform and prevail

If you love working with your agency partners for research, strategy, planning or events, keep going.

Latest news

  • The chief executive ostrich The chief executive ostrich

    Specialised as academic research is, I choose not to venture into evolutionary explanations of individual behaviour in the industry. ... Adventures with ostriches. First my two adventures. The first of these was with a firm who had asked me to guide its

  • Socially distanced strategising Socially distanced strategising

    As usual, let’s take a short cut to some practical recommendations via some management research. ... There’s no doubt that social distancing is a new threat to most firms’ traditional strategy processes.

  • FDA approves Sanofi’s key cancer drug Sarclisa for myeloma FDA approves Sanofi’s key cancer drug Sarclisa for myeloma

    clinical research at the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. ... Importantly, the approval of Sarclisa aligns with Sanofi’s narrower focus – last year, Hudson revealed a new strategy for the company, shedding

  • Roche and Illumina partner on genomics for cancer diagnostics Roche and Illumina partner on genomics for cancer diagnostics

    This builds upon our strategy of accelerating clinical research, streamlining workflows and expanding assay menus to broaden access to genomic data and lower barriers to routine use,” he added. ... This partnership complements and strengthens our

  • Lilly expands dermatology portfolio with $1.1bn Dermira deal Lilly expands dermatology portfolio with $1.1bn Dermira deal

    The acquisition of Dermira is consistent with Lilly's strategy to augment our own internal research by acquiring clinical phase assets in our core therapeutic areas and leveraging our development expertise

More from news
Approximately 2 fully matching, plus 65 partially matching documents found.

Latest Intelligence

  • Mastering oneself Mastering oneself

    What does it take to be a biomedical strategy expert? In the first article in this series, I wove together research about strategy and expertise to give a robust, demanding definition ... The first of these is the way strategy experts respond to new

  • The pursuit of patient diversity in clinical trials The pursuit of patient diversity in clinical trials

    Developing the right strategy is as much about communications – through patient engagement, community outreach, advocacy and education – as it is about study design, site selection and research methodology. ... Because if we’re going to reduce

  • AI and genomics: a revolution in drug discovery and development AI and genomics: a revolution in drug discovery and development

    Research strategy. Precisionlife’s system is designed around the so-called 5Rs principles of research effectiveness developed by AstraZeneca. ... In clinical research, for example, the strategy can be used to examine patient data sets to identify

  • Combining therapies and combining research Combining therapies and combining research

    Thankfully research is very much alive among the more agile, super-specialist research organisations. ... Very few companies are pursuing a combination therapy strategy. Helperby Therapeutics is at the forefront of antibiotic combinations for common

  • Escaping the spin cycle of sub-optimal launch Escaping the spin cycle of sub-optimal launch

    Rapid learning and the agile incorporation of new insight into brand strategy is essential. ... Our own research has found that while companies are good at identifying and developing deep customer insights, there’s room for improvement in how those

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

  • New faces at GCI Health, Porterhouse Medical and Research Partnership New faces at GCI Health, Porterhouse Medical and Research Partnership

    She has previous experience in market research in a communications and strategy consultancy. ... Research Partnership has also hired a further three employees to strengthen its US-based team.

  • The Foundry Healthcare appoints new head The Foundry Healthcare appoints new head

    I am particularly impressed with the agency’s approach to helping clients overcome sector-specific challenges using a combination of research-based insights, strategy development and creative solutions to inform and ... Working alongside The

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... The extensive experience Carole brings will

  • Biomunex appoints scientific and strategic advisors Biomunex appoints scientific and strategic advisors

    Dr Amigorena (pictured right) is currently a research director at Le Centre National de la Recherché Scientifique (CNRS) and is director of the Inserm Immunity and Cancer Unit at the Institut ... Prior to Covagen's sales to Johnson &Johnson in 2014, Dr

  • Branding Science adds to senior management team Branding Science adds to senior management team

    He founded Mojo in 2010 and has since served as research director, focused on delivering brand strategy for international pharmaceutical clients. ... In addition, Jon will further strengthen the scientific underpinnings of our market research and

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • Webinar:

    Understanding changing digital behaviours: Insights needed for an effective omnichannel strategy. ... Research experts Marc Yates, Roy Rogers and Paul Reed investigate changes in HCP and patients online behaviours and share market research techniques to

  • What do NHS changes and the Life Sciences Vision mean for medicines? What do NHS changes and the Life Sciences Vision mean for medicines?

    The launch of a new life sciences strategy is an important and positive step for industry. ... Also threaded through the strategy is the drive to increase research in the NHS and the harnessing of genomic and health data for this purpose.

  • YV Intelligence

    YV Intelligence is the top market research and business strategy consulting firm that offers in-depth market research reports and consulting services.

  • 5 strategies that will improve your clinical trial recruitment 5 strategies that will improve your clinical trial recruitment

    Plus, their relationship with patients can be really helpful in developing new methods of engaging patients in research. ... A solid patient retention strategy is just as important as your recruitment strategy (another previous blog looks at this in

  • GHO Capital and management acquire Ardian majority stake in Envision Pharma Group to accelerate continued growth GHO Capital and management acquire Ardian majority stake in Envision Pharma Group to accelerate continued growth

    Founded in 2001, Envision helps biopharmaceutical and medical device companies commercialize new compounds through medical strategy, strategic publications planning, and medical communications delivery. ... Its flagship technology iEnvision – a global

More from PMHub
Approximately 1 fully matching, plus 30 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...